Omega-3 supplementation and diabetes: A systematic review and meta-analysis
Omega-3 supplementation and diabetes: A systematic review and meta-analysis
Delpino et al., 2022 | Crit Rev Food Sci Nutr | Meta Analysis
Citation
Delpino Felipe Mendes, Figueiredo Lílian Munhoz, ... Gigante Denise Petrucci. Omega-3 supplementation and diabetes: A systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2022;62(16):4435-4448. doi:10.1080/10408398.2021.1875977
Abstract
This study aimed to review the literature on studies that evaluated the effects of omega-3 supplementation on parameters of diabetes in humans. An online search was conducted in the following databases: Pubmed, LILACS, Scielo, Scopus, and Web of Science. It included experimental studies that investigated the effects of omega-3 supplementation for diabetes treatment or prevention and its relationship with fasting blood glucose, insulin resistance, and glycated hemoglobin. Observational, non-human studies and non-randomized clinical trials were excluded. The Cochrane scale assessed the quality of the studies. A meta-analysis was carried out to evaluate the effect of omega-3 on fasting blood glucose, insulin resistance, and glycated hemoglobin. Thirty studies were included in the review. Almost 70% (n = 20) demonstrated at least one significant effect of the omega-3 supplementation related to diabetes. In the meta-analysis, there was a significant effect on the reduction of fasting blood glucose [SMD: -0.48; CI95%: -0.76, -0.19; p = 0.01; I2 = 88%] and insulin resistance [SMD: -0.61; CI95%: -0.98, -0.24; p = 0.01; I2 = 90%]. For glycated hemoglobin, there was no significant effect in the meta-analysis. This systematic review with meta-analysis demonstrated that supplementation with omega-3 has protective effects on diabetes parameters.
Key Findings
This systematic review with meta-analysis demonstrated that supplementation with omega-3 has protective effects on diabetes parameters.
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | See abstract |
| Sample Size | 20 |
| Age Range | See abstract |
| Condition | diabetes |
MeSH Terms
- Blood Glucose
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Dietary Supplements
- Fatty Acids, Omega-3
- Glycated Hemoglobin
- Humans
- Insulin Resistance
Evidence Classification
- Level: Meta Analysis
- Publication Types: Journal Article, Meta-Analysis, Systematic Review
- Vertical: omega-3
Provenance
- PMID: 33480268
- DOI: 10.1080/10408398.2021.1875977
- PMCID: Not in PMC
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09